The US Bio-Butadiene Market size was valued at USD 585 Million in 2025 and is projected to reach USD 1,870 Million by 2035, growing at a CAGR of 11.2% from 2024 to 2035. This market growth is spurred by increasing demand for sustainable chemicals and regulations restricting the use of fossil-based butadiene. Increasing investments in green technologies and rising applications in synthetic rubber are also fueling expansion.
The economic impact of tariffs on "US Bio-Butadiene Market".
US Bio-Butadiene Market Growth Drivers
Rising demand for sustainable chemicals in the automotive and tire industries is a major driver. Companies like Bridgestone Americas have partnered with sustainable chemical producers to develop bio-based tires, reducing carbon footprint and meeting regulatory requirements. The automotive sector’s transition towards green components, especially synthetic rubber made from bio-butadiene, is expected to drive substantial demand. As fuel efficiency and sustainability become critical considerations, tire makers are intensifying their collaborations with bio-butadiene suppliers, accelerating market growth.
Government support and favorable policies are enabling rapid expansion of the US bio-butadiene market. The US Department of Energy and the Environmental Protection Agency have introduced grants and incentives for bio-based chemical production, attracting investments from leading companies such as LanzaTech and Gevo. This support has led to R&D innovations and pilot commercial plants for bio-butadiene, encouraging the scaling up of production and catalyzing new project announcements. The regulatory push toward reducing greenhouse gas emissions is also motivating industries to pivot towards bio-based feedstocks.
US Bio-Butadiene Market Trends
Technological innovation in fermentation and catalyst technologies is a key trend, with companies like Genomatica working on advanced bio-based pathways to optimize yield and process efficiency. Emerging technologies such as engineered microbes and novel biocatalysts are contributing to cost reductions and improved scalability, thereby making bio-butadiene production more competitive with petrochemical routes. Collaborations between biotech firms and chemical manufacturers across the US are resulting in pilot projects, further validating the commercial potential of these innovations.
Increasing strategic alliances and partnerships between companies in the US bio-butadiene space are shaping the competitive landscape. For example, Goodyear Tire & Rubber Company and Green Biologics are exploring cooperative commercialization efforts to ensure reliable supply for high-value applications. Such partnerships not only accelerate technology transfer and resource sharing but also enable companies to address market and operational challenges together. This trend is likely to continue as more firms look to establish an early foothold in the growing market.
US Bio-Butadiene Market Opportunities
Expanding adoption of bio-butadiene in tire and automotive component manufacturing presents a significant growth opportunity for established and emerging companies. With consumer preference shifting toward sustainable mobility, tire makers and auto part suppliers are actively seeking bio-based alternatives, creating a lucrative environment for market participants like Goodyear and Bridgestone.
New investments in dedicated bio-refineries for commercial-scale bio-butadiene production are also an opportunity area. Market entrants can leverage supportive policies and co-location synergies with chemical clusters to set up cost-efficient operations, driving long-term demand and technological leadership.
US Bio-Butadiene Market Revenue (USD Million), 2020-2035
The chart represents projected revenue growth for the US Bio-Butadiene Market from 2020 to 2035. Starting from USD 180 million in 2020, market size increases steadily due to expanding demand for sustainable raw materials and policy-driven investments. The sharpest growth is observed post-2025, aligned with the commercial launch of several bio-butadiene projects by leading companies. By 2035, the market is poised to reach USD 1,870 million. The compound annual growth rate (CAGR) of 11.2% reflects robust momentum, particularly in the latter half of the forecast period, as automotive applications and regulatory support broaden the market base.
US Bio-Butadiene Market by Region Share (%) in 2025
The pie chart for 2025 indicates that the Midwest leads the US bio-butadiene market, holding 35% share, primarily due to significant industrial infrastructure and proximity to feedstock suppliers. The South follows with 28% market share, benefiting from established chemical production hubs. The West constitutes 17%, attributed to innovative startups and eco-friendly initiatives. The Northeast holds 12% share, driven by investment in advanced manufacturing, while 'Others' account for the remaining 8%. The dominance of the Midwest and South regions highlights the concentration of both supply chains and manufacturing activities in those areas.
US Bio-Butadiene Market Recent Developments
In May 2024, LanzaTech announced the successful commissioning of a 50,000 tons per year bio-butadiene demonstration plant in Illinois. The facility, developed in partnership with ADM and Bridgestone, marks a milestone in scaling up commercial bio-butadiene production in the US. Early production runs have already supplied key customers in the tire and rubber industry, showcasing the potential for drop-in replacements to fossil-based butadiene.
In April 2024, Genomatica reported the launch of its next-generation engineered yeast technology for bio-butadiene production. By boosting yield and reducing byproduct formation, the company claims a 15% cost reduction compared to previously deployed processes. Genomatica is piloting this novel process at a facility co-located with a Midwest ethanol plant, with plans to license the technology to US-based chemical manufacturers.
March 2024 saw Goodyear announce a multi-year supply agreement with Gevo, a prominent provider of renewable chemicals, for sourcing bio-butadiene based raw materials. This agreement will support Goodyear’s goals of achieving net-zero emissions for tire production by 2040 and serves as a blueprint for broader industry collaborations, accelerating commercial adoption of bio-based materials in the US.